Provantage Corporate Finance advises I Holland on their majority sale to Lagercrantz Group AB
Project: I Holland
Sector: Health & Pharma
Deal Value: Undisclosed
Provantage Corporate Finance is delighted to announce that it has acted as the exclusive lead adviser to the shareholders of I Holland, the Nottingham-based specialist and world-leading manufacturer of premium tablet compression tooling, on the sale of an 85% stake to Lagercrantz Group AB, the Stockholm-listed industrial technology group
Founded 80 years ago, I Holland is the world’s longest established supplier of punches, dies and other critical products to tablet producers. In partnership with research institutions and scientists, I Holland creates innovative solutions for leading pharma companies in more than 100 countries
The partnership with Lagercrantz marks an exciting new chapter for this Nottingham business, and brings the financial backing, industrial expertise and international scale needed to accelerate the company’s plans for growth. With the support of Lagercrantz, I Holland will invest further in technology, expand its capabilities, and strengthen its presence across global markets – while maintaining the long-standing relationships that underpin its success
Amanda Betts and Andy Shepherd, Provantage Corporate Finance, commented: “We are delighted to have supported the shareholders of I Holland on this significant milestone. The business has an exceptional reputation and a global customer base built on decades of trust, quality and technical expertise. Lagercrantz is an excellent partner for the next stage of development, and we look forward to seeing I Holland continue to grow as part of the group.”
The board of I Holland, added: “Amanda and Andy played a pivotal role in the success of this transaction. They were thorough, committed, and highly supportive, dedicating significant time to gain a deep understanding of the business and each seller as an individual. This approach ensured that the outcome was not only right for today but positioned the business for sustainable, long-term growth with the right partner going forward”.
For more information or to speak with our Health & Pharma team, please contact letstalk@provantagecf.com